Blackburn-based Big Presence has identified more than £4.2m in recoverable revenue for clients, weeks after their Growth Gap Analysis service was launched.
The Growth Gap Analysis assesses how businesses are using CRM platforms and other softwares to identify inefficiencies, disconnected systems and missed opportunities that could be affecting revenue and productivity. Rather than vague generalities, it puts a hard number on the value being left on the table and hands clients a prioritised, costed plan they can act on straight away.
A key part of the service is identifying practical opportunities to introduce AI and automation into existing workflows, particularly around reporting, lead management and operational efficiency.
Andy Coles, director of growth solutions at Big Presence, said: "Most of the businesses we look at are sitting on growth they've already paid for.
"They've invested in tech, but they're using a fraction of it. The Growth Gap Analysis shows them, in hard numbers, what that gap is costing, where additional revenue is and how quickly it can be closed.
"The fastest-growing businesses right now are not the ones spending more. They are the ones getting more out of what they already have. That is exactly the gap we help them find."
The early results are already landing with the businesses that have been through the process.
Tom Fielden, director at Service My, said: "We knew we had some inefficiencies, but the Growth Gap Analysis put it in black and white: where our processes were breaking down, how much time was disappearing into admin, and where the real growth opportunities were across sales and marketing. Genuinely one of the most useful exercises we've done."
Jonathan Finch, commercial director at Big Presence, said: "A lot of businesses don't realise how much inefficiency is already built into the way they operate.
"Once you make that visible, the opportunity becomes very clear. This is about helping companies see where value is being lost and giving them a practical way to act on it."
Bradley Tyson, founder of Refine Clinical Wholesale, said: "We went in expecting a broad overview and came out with a proper roadmap - a clear, costed view of where we were losing time and revenue, and a plain answer on what to tackle first. It has shaped how we've prioritised the whole year."















